Variable frequency drives (VFDs) are used in many industrial applications to improve energy efficiency and provide precise control over electric motors. By adjusting the frequency, voltage and current ...

CEO Joe Dominguez told investors that “on-grid” or “front-of-the-meter” configurations are becoming more attractive to the ...

Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the efficacy and safety of Cobenfy (xanomeline and trospium chloride) as an ...

A phase 3 trial in metastatic melanoma is ongoing, with a Biologics License Application expected by year-end. The vaccines offer a novel approach by targeting the entire tumor environment ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...

Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA potentially in ...

A tragic aviation incident occurred in Boca Raton, Florida, on Friday morning, as a small aircraft went down shortly after takeoff, resulting in the deaths of all three individuals on board ...

Sanofi is banking on the totality of data from the three phase 3 trials supporting potential filings for tolebrutinib, with the HERCULES result backed up by secondary endpoint data from the GEMINI ...

Data from the two phase 3 studies also showed that clinical decline was reduced in participants who had plasma p-tau181 reduction at 78 weeks, which Haeberlein said was a "meaningful" finding.

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...